These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12734329)

  • 21. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2B4-mediated activation of human natural killer cells.
    Tangye SG; Cherwinski H; Lanier LL; Phillips JH
    Mol Immunol; 2000 Jun; 37(9):493-501. PubMed ID: 11163399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of the dual functions of 2B4 (CD244).
    Chlewicki LK; Velikovsky CA; Balakrishnan V; Mariuzza RA; Kumar V
    J Immunol; 2008 Jun; 180(12):8159-67. PubMed ID: 18523281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).
    Watzl C; Stebbins CC; Long EO
    J Immunol; 2000 Oct; 165(7):3545-8. PubMed ID: 11034353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
    Sinha SK; Gao N; Guo Y; Yuan D
    J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
    Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
    J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
    Dhanji S; Teh HS
    J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2B4 co-stimulation: NK cells and their control of adaptive immune responses.
    Assarsson E; Kambayashi T; Persson CM; Ljunggren HG; Chambers BJ
    Mol Immunol; 2005 Feb; 42(4):419-23. PubMed ID: 15607793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional role of human NK cell receptor 2B4 (CD244) isoforms.
    Mathew SO; Rao KK; Kim JR; Bambard ND; Mathew PA
    Eur J Immunol; 2009 Jun; 39(6):1632-41. PubMed ID: 19499526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
    Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
    Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function.
    Klem J; Verrett PC; Kumar V; Schatzle JD
    J Immunol; 2002 Jul; 169(1):55-62. PubMed ID: 12077228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
    Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
    PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
    Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
    J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.
    Johnson LA; Vaidya SV; Goldfarb RH; Mathew PA
    Anticancer Res; 2003; 23(5A):3651-5. PubMed ID: 14666660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
    Vaidya SV; Mathew PA
    Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
    Margraf-Schönfeld S; Böhm C; Watzl C
    J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.